CZO: Bottoming!
Difficult to predict; but I think that we have hit the bottom this morning. Sentiment is way too negative for a company with solid fundamentals and promizing future that has recently received research funding award by Canadian Institutes for Health Research and MacMaster University (for PGX). CZO's transformation to a new business model into a biopharmaceutical development co should be recognized in the near future and the price of the stock should react accordingly when listed on the US Market. Patience will pay!